Valuation : aap Implantate AG

Market Cap 24.2M 28.13M 22.79M 20.76M 38.85M 2.68B 39.01M 270M 104M 1.36B 106M 103M 4.32B P/E 2024
-3.6x
P/E 2025 -7.58x
Enterprise Value 23.89M 27.76M 22.49M 20.49M 38.35M 2.64B 38.5M 267M 103M 1.35B 104M 102M 4.26B EV / Sales 2024
1.32x
EV / Sales 2025 1.56x
Free-Float
38.19%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 64 2019-04-30
Director of Finance/CFO - 2026-08-18
Chief Operating Officer - 2026-08-18
Director TitleAgeSince
Director/Board Member 70 2015-12-31
Chairman 55 2019-07-03
Director/Board Member 50 2021-10-31
Change 5-day change 1-year change 3-year change Capi.($)
-2.67%-9.32% - - 28.13M
-0.51%-3.83%-19.12%+2.12% 182B
+0.23%-1.35%-0.52%+12.83% 118B
+0.17%-3.27%+10.08%+83.53% 61.7B
-0.32%-5.42%+11.66%+43.87% 50.55B
-1.33%-5.16%-5.57%-33.40% 48.98B
-0.20%-6.40%+10.49%-21.74% 31.65B
-4.05%-9.31% - - 29.87B
-1.34%-2.82%+30.50%-16.13% 23.71B
-1.46%-9.42%-13.71%+4.34% 21.78B
Average -1.17%-4.02%+2.98%+9.43% 63.1B
Weighted average by Cap. -0.63%-3.00%-3.43%+12.37%

Financials

2024 2025
Net sales 12.2M 14.18M 11.49M 10.47M 19.59M 1.35B 19.67M 136M 52.63M 687M 53.25M 52.09M 2.18B 12.49M 14.51M 11.76M 10.71M 20.04M 1.38B 20.12M 139M 53.86M 703M 54.49M 53.31M 2.23B
Net income -3.63M -4.22M -3.42M -3.11M -5.83M -401M -5.85M -40.51M -15.66M -205M -15.84M -15.5M -648M -2.58M -3M -2.43M -2.22M -4.15M -286M -4.17M -28.85M -11.15M -146M -11.28M -11.04M -461M
Net Debt -1.1M -1.28M -1.04M -945K -1.77M -122M -1.77M -12.29M -4.75M -62.03M -4.8M -4.7M -197M -314K -365K -296K -269K -504K -34.72M -506K -3.5M -1.35M -17.69M -1.37M -1.34M -56.04M
Logo aap Implantate AG
aap Implantate AG is a Germany-based provider of medical devices for human muscular and skeletal systems. The Company focuses on trauma and biomaterials products for orthopedics. The Biomaterials portfolio comprises bone substitutes for the filling of aseptic bone defects, bone cements and accessories for the application in arthroplasty, bone cements and accessories for the application in vertebroplasty and kyphoplasty. The trauma portfolio includes a wide range of cannulated screws, standard plates and screws for miniature, small and large bone fragments, among others . It also develops LOQTEQ, a technology that allows for fracture compression with subsequent locking fixation in one surgical step. The Company operates a network of distributors in more than 60 countries, and cooperates directly with physicians and hospital customers.
Employees
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!